Abstract
Mannan-binding lectin (MBL) is an important factor of innate immunity contributing to the clearance of microorganisms. Recently, an antitumourigenic role of MBL has been suggested. We investigated mbl2 genotypes, MBL concentrations, and MBL-MASP-2 complex activity in patients with ovarian cancer. The expression of both mbl2 and masp-2 genes were investigated in ovarian tissue sections. Additionally, samples from patients with other malignant and benign tumours of the reproductive tract were tested. A significantly higher incidence of MBL deficiency/insufficiency-associated genotypes was found among patients with malignant disease compared to age-matched controls. Unexpectedly, no differences in median MBL level or MBL-MASP-2 complex activity were found between the groups. This was partly a reflection of higher MBL concentrations and MBL-MASP-2 activity in cancer patients compared with healthy women carrying corresponding genotypes. MBL-specific mRNA expression was detected in several normal and malignant ovarian tissues, as well as in ovarian epithelial cell lines. Intracellular staining with MBL-specific antibodies demonstrated the presence of MBL in ovarian cell lines, and in normal as well as malignant ovarian tissue sections. In contrast, MASP-2-specific mRNA expression was detected only in the ovary tissues of patients with malignant disease. No significant changes in MBL concentration during 3 months of chemotherapy were noticed. MBL was detected in ascites and in the fluid of benign ovarian cysts. Our findings may reflect anti-tumourigenic activity of MBL protein which might suggest potential therapeutic application. However, it cannot be excluded that mbl-2 mutant alleles may be in linkage disequilibrium with an unidentified tumour susceptibility gene(s).
Similar content being viewed by others
Abbreviations
- mAb:
-
Monoclonal antibody
- MASP:
-
MBL-associated serine protease
- MBL:
-
Mannan-binding lectin
- MMP:
-
Metalloprotease
- SLO:
-
Second look laparotomy
References
Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS (2003) Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 37:733–737
Baccarelli A, Hou L, Chen J, Lissowska J, El-Omar EM, Grillo P, Giacornini SM, Yaeger M, Bernig T, Zatonski W, Fraumeni JF, Chanock SJ, Chow WH (2006) Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 118:1970–1975
Bąk-Romaniszyn L, Cedzyński M, Szemraj J, Świerzko ASt, Zeman K, Kałużyński A, Płaneta-Małecka I (2006) Mannan-binding lectin in children with chronic gastritis. Scand J Immunol 63:131–135
Bellavia D, Frada G, Di Franco P, Feo S, Franceschi C, Sansoni P, Brai M (1999) C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians. J Gerontol A Biol Sci Med Sci 54:B150–B153
Bergmann OJ, Christiansen M, Laursen I, Bang P, Hansen NE, Ellegaard J, Koch C, Andersen V (2003) Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 70:91–97
Bjorge L, Hakulinen J, Vintermyr OK, Jarva H, Jensen TS, Iversen OE, Meri S (2005) Ascitic complement system in ovarian cancer. Br J Cancer 92:895–905
Butler GS, Sim D, Tam E, Devine D, Overall CM (2002) Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis: potential role in human in MBL deficiency. J Biol Chem 277:17511–17519
Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group (2006) Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98:303–315
Cedzyński M, Szemraj J, Świerzko ASt, Bąk-Romaniszyn L, Banasik M, Zeman K, Kilpatrick DC (2004) Mannan-binding lectin (MBL) insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 136:304–311
Chomczynski P (1993) A reagent for single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 3:532–537
DePinho RA (2000) The age of cancer. Nature 408:248–254
Downing I, MacDonald SL, Turner ML, Kilpatrick DC (2005) Detection of an autologous ligand for mannan-binding lectin on human B lymphocytes. Scand J Immunol 62:507–514
Fujita T, Taira S, Kodama N, Matsushita M, Fujita T (1995) Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma via the lectin pathway. Jpn J Cancer Res 86:187–192
Garred P, Brygge K, Sorensen CH, Madsen HO, Thiel S, Svejgaard A (1993) Mannan-binding protein-levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clin Exp Immunol 94:99–104
Ghahremani M, Foghi A, Dorrington JH (1999) Etiology of ovarian cancer: a proposed mechanism. Med Hypotheses 52:23–26
Gomez CR, Boehmer ED, Kovacs EJ (2005) The aging innate immune system. Curr Opin Immunol 17:457–462
Hasty LA, Lambris JD, Lessey BA, Pruksananonda K, Lyttle CR (1994) Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol 170:168–175
Hirano M, Ma BY, Kawasaki N, Okimura K, Baba M, Nakagawa T, Miwa K, Kawasaki N, Oka S, Kawasaki T (2005) Mannan-binding protein blocks the activation of metalloproteases meprin α and β. J Immunol 175:3177–3185
Horiuchi T, Gondo H, Miyagawa H, Otsuka J, Inaba S, Nagafuji K, Takase K, Tsukamoto H, Koyama T, Mitoma H, Tamimoto Y, Miyagi Y, Tahira T, Hayashi K, Hashimura C, Okamura S, Harada M (2005) Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotheraphy and autologous PBSCT. Genes Immun 6:162–166
Kelly P, Jack DL, Naeem A, Mandanda B, Pollok RC, Klein NJ, Turner MW, Farthing MJ (2000) Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology 119:1236–1242
Kilpatrick DC (2002) Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta, 1572:401–413
Kilpatrick DC, McLintock LA, Allan EK, Copland M, Fujita T, Jordanides NE, Koch C, Matsushita M, Shiraki H, Stewart K, Tsujimura M, Turner ML, Franklin IM, Holyoake TL (2003) No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy related infections. Clin Exp Immunol 134:279–284
Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J (2001) Senescent fibroblasts promote epithelial cell growth and tumourigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 98:12072–12077
Kuper H, Adami HO, Trichopoulos D (2000) Infections as a major preventable cause of human cancer. J Int Med 248:171–183
Lanzrein AS, Jobst KA, Thiel S, Jensenius JC, Sim RB, Perry VH, Sim E (1998) Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer’s disease. Neuroreport 9:1491–1495
Lee KW, Im SA, Yun T, Song EK, Na II, Shin H, Choi IS, Oh DY, Kim JH, Kim DW, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK (2005) Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer. Jpn J Clin Oncol 35:720–726
Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T (1999) Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein-dependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA 96:371–375
MacNeill C, Umstead TM, Phelps DS, Lin Z, Floros J, Shearer DA, Weisz J (2004) Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid. Immunology 111:91–99
Madsen HO, Garred P, Thiel S, Kurzhals JAL, Lamm LU, Ryder LP, Svjegaard A (1995) Interplay between promoter and structural polymorphism of the human-binding-protein. J Immunol 155:3013–3020
Malhotra R, Willis AC, Lopez Bernal A, Thiel S, Sim RB (1994) Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collectin receptor from amnion cells. Immunology 82:439–444
Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237–243
Manzano A, Roig T, Bermudez J, Bartrons R (1996) Effects of taxol on isolated rat hepatocyte metabolism. Am J Physiol 271:C1957–C1962
Murdoch WJ, McDonnel AC (2002) Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123:743–750
Muto S, Takada T, Matsumoto K (2001) Biological activities of human mannose-binding lectin bound to two different ligand sugar structures, Lewis A and Lewis B antigens and high-mannose type oligosaccharides. Biochim Biophys Acta 1527:39–46
Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, Borrias-Essers MC, Ryder LP, Koch C, Garred P (2003) Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 33:2853–2863
Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459–1467
Ness RB, Goodman MT, Shen C, Brunham RC (2003) Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J Infect Dis 187:1147–1152
Neth O, Hann I, Turner MW, Klein NJ (2001) Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358:614–618
Neth O, Jack DL, Johnson M, Klein NJ, Turner MW (2002) Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J Immunol 169:4430–4436
Nishioka K, Kawamura K, Hirayama T, Kawashima T, Shimada K (1976) The complement system in tumor immunity: significance of elevated levels of complement in tumor bearing hosts. Ann N Y Acad Sci 276:303–315
Oberley RE, Goss KL, Ault KA, Crouch EC, Snyder JM (2004) Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infection. Mol Hum Reprod 10:861–870
Ostoros G, Pretz A, Fillinger J, Soltesz I, Dome B (2006) Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature. Int J Gynecol Cancer 16(suppl 1):391–393
Pellis V, De Seta F, Crovella S, Bossi F, Bulla R, Guaschino S, Radillo O, Garred P, Tedesco F (2005) Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin Exp Immunol 139:120–126
Reading PC, Hartley CA, Ezekowitz RA, Anders EM (1995) A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun 217:1128–1136
Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT (2000) Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 81:949–955
Sakata K, Shigemasa K, Uebaba Y, Nagai N, Ohama K (2002) Expression of matrix metalloproteinases-2 and -9 by cells isolated from the peritoneal fluid of women with ovarian carcinoma. Acta Cytol 46:697–703
Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER (2005) Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162:668–675
Santos IK, Costa CH, Krieger H, Feitosa MF, Zurakowski D, Fardin B, Gomes RB, Weiner DL, Harn DA, Ezekowitz RA, Epstein JE (2001) Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 69:5212–5215
Sastry K, Herman GA, Day L, Deignan E, Bruns G, Morton CC, Ezekowitz RA (1989) The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 170:1175–1189
Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E (2001) Increased expression of matrix metalloproteinasses (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7:2396–2404
Schmiegelow K, Garred P, Lausen B, Andreassen B, Petersen BL, Madsen HO (2002) Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. Blood 100:3757–3760
Seyfarth J, Garred P, Madsen HO (2006) Extra-hepatic transcription of the human mannose-bidning lectin gene (mbl2) and the MBL-associated serine protease 1–3 genes. Mol Immunol 43:962–971
Siassi M, Riese J, Steffensen R, Meisner M, Thiel S, Hohenberger W, Schmidt J (2005) Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care 9:R483–R489
Swanson AF, Ezekowitz RA, Lee A, Kuo CC (1998) Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun 66:1607–1612
Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC (1992) The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 90:31–35
Thomas HC, Foster GR, Sumiya M, McIntosh D, Jack DL, Turner MW, Summerfield JA, (1996) Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 348:1417–1419
Tregoat V, Montagne P, Bene MC, Faure G (2002) Changes in the mannan binding lectin (MBL) concentration in human milk during lactation. J Clin Lab Anal 16:304–307
Urban A, Miszczyk L (2003) Ovarian cancer—diagnostical and therapeutical dilema of oncological gynecology (in Polish). Wspolcz Onkol 7:294–300
Verma A, Matta A, Shukla NK, Deo SV, Gupta SD, Ralhan R (2006) Clinical significance of mannose-binding lectin-associated serine protease-2 expression in esophageal squamous cell carcinoma. Int J Cancer 118:2930–2935
Wallis R, Dodd RB (2000) Interaction of mannose-binding protein with associated serine proteases: effects of naturally occurring mutations. J Biol Chem 275:30962–30969
Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase–polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41–49
Yang CQ, Chan KY, Ngan HY, Khoo US, Chiu PM, Chan QK, Xue WC, Cheung AN (2006) Single nucleotide polymorphisms of follicle stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 27:1502–1506
Ytting H, Christensen IJ, Thiel S, Jensenius JC, Nielsen HJ (2005) Serum mannan-binding lectin-associated serine protease 2 levels in coloreactal cancer: relation to recurrence and mortality. Clin Cancer Res 11:1441–1446
Ytting H, Christensen IJ, Jensenius JC, Thiel S, Nielsen HJ (2005) Preoperative mannan-binding lectin pathway and prognosis in coloreactal cancer. Cancer Immunol Immunother 54:265–272
Acknowledgment
This work was partially supported by Ministry of Education and Science (Poland), grant 3 P05A 025 24. Authors co-operate within the Polish Research Network “The molecular basis of immunity”. We thank Dr. D. C. Kilpatrick for critically reading the manuscript and helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Świerzko, A.S., Florczak, K., Cedzyński, M. et al. Mannan-binding lectin (MBL) in women with tumours of the reproductive system. Cancer Immunol Immunother 56, 959–971 (2007). https://doi.org/10.1007/s00262-006-0250-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-006-0250-7